🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 18 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/03/2014 | 48,25 | 49,86 | 48,16 | 49,64 | +3,42% | 3,53% | 417.421 |
| 17/03/2014 | 47,21 | 49,46 | 47,20 | 48,00 | +2,07% | 4,78% | 625.491 |
| 14/03/2014 | 45,10 | 47,26 | 44,34 | 47,03 | +4,04% | 6,47% | 709.648 |
| 13/03/2014 | 46,02 | 47,48 | 44,55 | 45,20 | -1,01% | 6,36% | 627.895 |
| 12/03/2014 | 43,64 | 45,77 | 43,06 | 45,66 | +3,73% | 6,22% | 366.927 |
| 11/03/2014 | 43,87 | 45,58 | 43,36 | 44,02 | +0,53% | 5,06% | 701.473 |
| 10/03/2014 | 43,34 | 44,43 | 42,69 | 43,79 | +0,60% | 4,02% | 436.657 |
| 07/03/2014 | 43,62 | 43,86 | 41,58 | 43,53 | +0,77% | 5,22% | 435.215 |
| 06/03/2014 | 46,28 | 46,36 | 43,14 | 43,20 | -6,33% | 6,94% | 516.487 |
| 05/03/2014 | 46,16 | 47,69 | 45,88 | 46,12 | +0,53% | 3,92% | 675.504 |
| 04/03/2014 | 43,81 | 46,08 | 43,81 | 45,88 | +6,43% | 5,18% | 825.866 |
| 03/03/2014 | 42,99 | 43,40 | 41,80 | 43,11 | -0,93% | 3,73% | 403.796 |
| 28/02/2014 | 44,60 | 46,40 | 43,07 | 43,51 | -2,38% | 7,47% | 758.379 |
| 27/02/2014 | 45,06 | 45,55 | 44,30 | 44,57 | -1,26% | 2,77% | 473.847 |
| 26/02/2014 | 45,95 | 46,51 | 44,78 | 45,14 | -1,84% | 3,76% | 386.163 |
| 25/02/2014 | 46,69 | 48,31 | 45,94 | 45,99 | -0,99% | 5,08% | 911.466 |
| 24/02/2014 | 46,79 | 48,01 | 46,40 | 46,45 | +0,04% | 3,44% | 468.397 |
| 21/02/2014 | 45,71 | 47,04 | 45,15 | 46,43 | +1,85% | 4,12% | 642.963 |
| 20/02/2014 | 45,51 | 45,83 | 45,09 | 45,59 | +0,76% | 1,62% | 823.461 |
| 19/02/2014 | 46,13 | 47,26 | 45,00 | 45,25 | -1,91% | 4,91% | 597.118 |
| 18/02/2014 | 48,33 | 48,91 | 45,41 | 46,13 | -3,87% | 7,23% | 1.240.722 |
| 14/02/2014 | 49,46 | 50,17 | 47,47 | 47,99 | -2,82% | 5,45% | 885.016 |
| 13/02/2014 | 45,68 | 49,71 | 45,54 | 49,38 | +6,36% | 9,14% | 1.078.498 |
| 12/02/2014 | 44,36 | 47,89 | 43,67 | 46,43 | +4,27% | 9,52% | 2.018.979 |
| 11/02/2014 | 39,28 | 44,87 | 39,28 | 44,52 | +13,83% | 14,23% | 2.021.704 |
| 10/02/2014 | 38,22 | 39,25 | 37,12 | 39,11 | +4,33% | 5,58% | 595.515 |
| 07/02/2014 | 35,46 | 37,95 | 35,46 | 37,49 | +5,77% | 7,02% | 424.795 |
| 06/02/2014 | 35,82 | 36,43 | 35,02 | 35,45 | -0,58% | 3,92% | 306.975 |
| 05/02/2014 | 36,62 | 36,77 | 34,07 | 35,65 | -3,67% | 7,38% | 681.756 |
| 04/02/2014 | 37,02 | 37,53 | 36,60 | 37,01 | +0,61% | 2,51% | 336.149 |